Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended in June - Earnings Summary

Corbus Pharmaceuticals Holdings

08/08/2023 14:42

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ  reported a
quarterly adjusted loss of $2.05​​ per share for the quarter
ended in June. The lone analyst forecast for the quarter was
for a loss of $3.10 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Corbus Pharmaceuticals Holdings Inc's reported EPS for the
quarter was a loss of $2.05​.
    * The mean earnings estimate of analysts had fallen by
about 31.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Corbus Pharmaceuticals Holdings Inc shares had fallen
by 17.7%
this quarter and gained 94.6% so far this year.
    * The company reported a quarterly loss of $8.78 million.
    * Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $71.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -3.10          -2.05          Beat
 Mar. 31 2023      -4.09          -4.24          Missed
 Dec. 31 2022      -2.10          -2.61          Missed
 Sep. 30 2022      -1.65          -2.10          Missed